Dr Reddy’s Lab Share Price Gained 3.25% Intraday on December 20, 2024

On December 20, 2024, Dr Reddy’s Laboratories share price traded 2.50% higher at ₹1,358.70 at 1:01 PM (IST), outperforming the broader market as the BSE Sensex plunged by 687.43 points to 78,530.62. The stock has shown significant movement over the past year, with a 52-week high of ₹1,420.20 on August 21, 2024, and a 52-week low of ₹1,094.88 on December 21, 2023.

As per BSE data, the stock recorded a total traded volume of 1.35 lakh shares, amounting to a turnover of ₹18.34 crore. At the current price, Dr Reddy’s shares are trading at a price-to-earnings (P/E) ratio of 4.71x, based on trailing 12-month EPS of ₹288.19, and a price-to-book (P/B) ratio of 0.84. With a beta value of 0.41, the stock shows lower volatility compared to the broader market.

Shareholding Pattern 

As of September 30, 2024, promoters held a 26.64% stake in the company, while Foreign Institutional Investors (FIIs) owned 27.53%, and Domestic Institutional Investors (DIIs) held 21.48%.

Q2 FY25 Performance

Dr Reddy’s Laboratories recently reported its Q2 FY25 results, revealing a revenue of ₹80,162 million, reflecting strong growth. However, net profit for the quarter fell to ₹1,341.9 crore. The company’s EBITDA was reported at ₹2,076.5 crores, with R&D expenses totalling ₹7,271 million, underscoring its focus on innovation despite challenges to profitability.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.